Middle East & Africa Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis - By Ulcer Type, Treatment Type, Infection Severity, and End User

Description

List of Tables

The Middle East & Africa diabetic foot ulcer market was valued at US$ 249.80 million in 2022 and is expected to reach US$ 352.45 million by 2030; it is estimated to grow at a CAGR of 4.4% from 2022 to 2030.

High Prevalence of Diabetes and Related Chronic Wounds Fuel the Middle East & Africa Diabetic Foot Ulcer Market

Diabetic patients are vulnerable to wounds, and the healing process is usually longer. Depending on healing timeframe, wounds are classified as acute and chronic. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes can lead to various complications in different body parts and increase the overall risk of premature death. According to the International Diabetes Federation (IDF), in 2021, there were ~537 million adults living with diabetes worldwide. The number is anticipated to increase to 643 million by 2030 and 783 million by 2045. Blood vessels and nerves in the feet of diabetic patients are prone to damages, resulting in numbness. Due to this, diabetic patients have a higher chance of developing diabetic foot ulceration.

According to a study published in 2021 in National Center for Biotechnology Information (NCBI), the risk of developing diabetic foot ulcers is between 19% and 34%. Approximately, a recurrence rate of 40% is experienced by patients within 1 year of recovery, 60% within 3 years, and 65% within 5 years. As per same study, it is reported that infection develops in 50-60% of ulcers and is the principal cause that damages diabetic feet. Thus, the demand for diabetic foot ulcer treatments is on rise globally, thereby fueling the market growth.

Middle East & Africa Diabetic Foot Ulcer Market Overview

The Middle East & Africa diabetic foot ulcer market is estimated to grow at a CAGR of 6.4% from 2022 to 2030. Key factors driving the market growth are increasing prevalence of diabetes and related chronic wounds and the rise in geriatric population propel market growth. However, high cost of advanced wound care treatments hinders the market growth. In the last few years, the private sector has been playing an important role in the healthcare system in Saudi Arabia, owing to the rising investments in the development of healthcare facilities and infrastructure in the country. The Government of Saudi Arabia launched the Saudi Vision 2030 program to reduce oil dependence and diversify other sectors, including healthcare. Under this program, the Health Sector Transformation Program aims to reconstruct the healthcare sector as a comprehensive, effective, and integrated health system based on the health of individuals. Thus, the increasing investments in developing healthcare facilities and the increasing prevalence of diabetes among the population will fuel the market growth in the Middle East & Africa.

Middle East & Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Diabetic Foot Ulcer Market Segmentation

Based on treatment type, the Middle East & Africa diabetic foot ulcer market is segmented into advanced wound care dressings, therapy device, and biologics. The advanced wound care dressings segment held the largest share in 2022.

Based on ulcer type, the Middle East & Africa diabetic foot ulcer market is segmented into neuro-lschemic ulcers, neuropathic ulcers, and ischemic ulcers. The neuro-lschemic ulcers segment held the largest share in 2022.

Based on infection severity, the Middle East & Africa diabetic foot ulcer market is segmented into mild, moderate, and severe. The mild segment held the largest share in 2022.

Based on end user, the Middle East & Africa diabetic foot ulcer market is segmented into hospitals, ambulatory surgical centers, and home care. The hospitals segment held largest share in 2022.

Based on country, the Middle East & Africa diabetic foot ulcer market is segmented into South Africa, Saudi Arabia, UAE, and the Rest of MEA. South Africa dominated the Middle East & Africa diabetic foot ulcer market in 2022.

Convatec Group Plc, 3M Co, Coloplast AS, Smith & Nephew Plc, B. Braun SE, Medline Industries LP, Organogenesis Inc., Molnlycke Health Care AB, and MiMedx Group Inc are some of the leading companies operating in the Middle East & Africa diabetic foot ulcer market.

Product Code: BMIRE00029573

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa Diabetic Foot Ulcer Market Landscape

4.1 Overview

5. Middle East & Africa Diabetic Foot Ulcer Market - Key Industry Dynamics

5.1 Market Drivers:
- 5.1.1 High Prevalence of Diabetes and Related Chronic Wounds
- 5.1.2 Surge in Geriatric Population
- 5.1.3 High Cost of Advanced Wound Care Treatments
5.2 Market Opportunities
- 5.2.1 Growing Research Activities to Unveil Novel Wound Treatment Products
5.3 Future Trends
- 5.3.1 Use of 3D Printing in Wound Care Management
5.4 Impact Analysis:

6. Diabetic Foot Ulcer Market - Middle East & Africa Market Analysis

6.1 Middle East & Africa Diabetic Foot Ulcer Market Revenue (US$ Mn), 2022 - 2030

7. Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - by Treatment Type

7.1 Overview
7.2 Middle East & Africa Diabetic Foot Ulcer Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Advanced Wound Care Dressings
- 7.3.1 Overview
- 7.3.2 Advanced Wound Care Dressings: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.3 Alginate Dressings
  - 7.3.3.1 Overview
  - 7.3.3.2 Alginate Dressings: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.4 Hydrofiber Dressings
  - 7.3.4.1 Overview
  - 7.3.4.2 Hydrofiber Dressings: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.5 Foam Dressings
  - 7.3.5.1 Overview
  - 7.3.5.2 Foam Dressings: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.6 Collagen Dressing
  - 7.3.6.1 Overview
  - 7.3.6.2 Collagen Dressing: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.7 Film Dressing
  - 7.3.7.1 Overview
  - 7.3.7.2 Film Dressing: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3.8 Other Dressings
  - 7.3.8.1 Overview
  - 7.3.8.2 Other Dressing: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Biologics
- 7.4.1 Overview
- 7.4.2 Biologics: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.3 Growth Factors
  - 7.4.3.1 Overview
  - 7.4.3.2 Growth Factors: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.4.4 Skin Graft
  - 7.4.4.1 Overview
  - 7.4.4.2 Skin Graft: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Therapy Device
- 7.5.1 Overview
- 7.5.2 Therapy Device: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5.3 Negative Pressure Wound Therapy
  - 7.5.3.1 Overview
  - 7.5.3.2 Negative Pressure Wound Therapy: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 7.5.4 Ultrasound Therapy
  - 7.5.4.1 Overview
  - 7.5.4.2 Ultrasound Therapy: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Ulcer Type

8.1 Overview
8.2 Middle East & Africa Diabetic Foot Ulcer Market Revenue Share, By Ulcer Type 2022 & 2030 (%)
8.3 Neuropathic Ulcers
- 8.3.1 Overview
- 8.3.2 Neuropathic Ulcers: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Ischemic Ulcers
- 8.4.1 Overview
- 8.4.2 Ischemic Ulcers: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Neuro-ischemic Ulcers
- 8.5.1 Overview
- 8.5.2 Neuro-ischemic Ulcers: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By Infection Severity

9.1 Overview
9.2 Middle East & Africa Diabetic Foot Ulcer Market Revenue Share, By Infection Severity 2022 & 2030 (%)
9.3 Mild, Moderate, and Severe
- 9.3.1 Overview
- 9.3.2 Mild: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 9.3.3 Moderate: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
- 9.3.4 Severe: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 - By End User

10.1 Overview
10.2 Middle East & Africa Diabetic Foot Ulcer Market Revenue Share, By End User 2022 & 2030 (%)
10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 Hospitals: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgical Centers: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Home Care
- 10.5.1 Overview
- 10.5.2 Home Care: Middle East & Africa Diabetic Foot Ulcer Market - Revenue and Forecast to 2030 (US$ Million)

11. Diabetic Foot Ulcer Market - Middle East & Africa Country Analysis

11.1 Middle East & Africa Diabetic Foot Ulcer Market, Revenue and Forecast to 2030
- 11.1.1 Overview
  - 11.1.1.1 Middle East & Africa Diabetic Foot Ulcer Market by Country
  - 11.1.1.2 UAE
    - 11.1.1.2.1 UAE Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.2.2 UAE Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.2.3 UAE Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.2.3.1 UAE: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.2.3.2 UAE: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.2.3.3 UAE: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.2.4 UAE Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.2.5 UAE Diabetic Foot Ulcer Market, by End User
  - 11.1.1.3 Saudi Arabia
    - 11.1.1.3.1 Saudi Arabia Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.3.2 Saudi Arabia Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.3.3 Saudi Arabia Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.3.3.1 Saudi Arabia: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.3.3.2 Saudi Arabia: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.3.3.3 Saudi Arabia: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.3.4 Saudi Arabia Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.3.5 Saudi Arabia Diabetic Foot Ulcer Market, by End User
  - 11.1.1.4 South Africa
    - 11.1.1.4.1 South Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.4.2 South Africa Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.4.3 South Africa Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.4.3.1 South Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.4.3.2 South Africa: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.4.3.3 South Africa: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.4.4 South Africa Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.4.5 South Africa Diabetic Foot Ulcer Market, by End User
  - 11.1.1.5 Rest of Middle East & Africa
    - 11.1.1.5.1 Overview
    - 11.1.1.5.2 Rest of Middle East & Africa Diabetic Foot Ulcer Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.5.3 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Ulcer Type
    - 11.1.1.5.4 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Treatment Type
    - 11.1.1.5.4.1 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Advanced Wound Care Dressings, 2030 (USD Million)
    - 11.1.1.5.4.2 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Therapy Device, 2030 (USD Million)
    - 11.1.1.5.4.3 Rest of Middle East & Africa: Diabetic Foot Ulcer Market, by Biologics, 2030 (USD Million)
    - 11.1.1.5.5 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by Infection Severity
    - 11.1.1.5.6 Rest of Middle East & Africa Diabetic Foot Ulcer Market, by End User

12. Diabetic Foot Ulcer Market Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Middle East & Africa Diabetic Foot Ulcer Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Middle East & Africa Diabetic Foot Ulcer Market - Key Company Profiles

13.1 Convatec Group Plc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 3M Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Coloplast AS
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Smith & Nephew Plc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 B. Braun SE
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Molnlycke Health Care AB
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 MiMedx Group Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Medline Industries LP
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Organogenesis Inc.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms